Notre Dame, Purdue and GE Healthcare partner on "ultra low" radiation-dose, high clarity CT technology
Demonstrating their shared legacy of innovative research and commitment to patient-centered medical technology, the University of Notre Dame, Purdue University and GE Healthcare have announced the commercial availability of a new CT scanning technology, called Veo, that enables physicians to diagnose patients with high clarity images at previously-unattainable low radiation dose levels.
CT is an advanced form of spiral x-ray technology that physicians use to help diagnosis disease in their patients including cancer, cardiac and neurological diseases, and other conditions with the goal of significantly improving treatment plans and patient health outcomes. Since it was invented in the 1970s, CT scanning has helped save and improve millions of lives. Still, physicians and patients have traditionally had to balance the tremendous benefits of CT with the patients exposure to limited medical radiation dose used during scanning. As such, the publics awareness of CTs benefits and the potential risks from a radiation perspective has grown in recent years.
Veo has changed the equation helping healthcare professionals provide accurate diagnoses with high clarity images at astonishingly low radiation dose levels.
Veo technology is a game-changer, plain and simple, said Steve Gray, vice president and general manager of CT and Advantage Workstation for GE Healthcare. Traditionally in CT there has been a trade-off between high image quality for the physician and low radiation dose for the patient. Were hearing from hospitals that this trade-off is beginning to dissipate, as Veo delivers startlingly clear images at unprecedented low dose levels.
The worlds first Model-Based Interactive Reconstruction technology, Veo is built on an advanced algorithm that was developed jointly by researchers at Purdue, Notre Dame and GE Healthcare. The three organizations signed a commercialization agreement allowing Veo to be commercialized through the Purdue Research Foundations Office of Technology Commercialization program and Notre Dames Office of Technology Transfer.
Were pleased to have our engineering research contribute to a viable new product, particularly in an area so critical to our economy and our well-being as revolutionary medical diagnostics devices, said Bob Bernhard, vice president for research at Notre Dame. We see the Veo project as a great example of close collaboration of university and industry.
The development of this discovery is another excellent example of how a collaboration between Purdue and another institution, in this case Notre Dame, has resulted in a viable product that is being commercialized, said Joseph B. Hornett, senior vice president, treasurer and COO of the Purdue Research Foundation. Last year, we signed 85 commercialization agreements to move Purdue discoveries to the public.
Veo was granted Food and Drug Administration clearance in the U.S. earlier this year.
Charles A. Bouman, the Michael J. and Katherine R. Birck Professor of Electrical and Computer Engineering and a professor of biomedical engineering at Purdue University, and Ken Sauer, associate professor of electrical engineering at Notre Dame, developed the technology over the past two decades in collaboration with Jean-Baptiste Thibault, Jiang Hsieh and Zhou Yu. Thibault and Yu worked on the technology as graduate assistants under Bouman and Sauer and both currently work for GE Healthcare.
Conventional CT scanning takes thousands of views from different angles to see organs, and then creates a 3-D image of the person, Bouman said. "Veo takes radiographic images digitally that use less light. A reduction in light means the radiation dosage is reduced. Then our computer algorithm uses model-based reconstruction more effectively so we can form a high-quality image with less radiation.
Basically, Veo cleans up the noise or graininess and creates a sharper image.
After simultaneously completing their Ph.D.s at Princeton University, Bouman and Sauer began working on the technology as assistant professors at Purdue and Notre Dame.
Our opportunity to work closely with our collaborators at GE Healthcare was immensely important in getting these imaging ideas into the scanners, Sauer said. The fact the Jean-Baptiste and Jiang committed themselves to guiding this project and had direct access to other experts on every facet of the machines really tightened the feedback loop on algorithmic improvements.
Funding for the research came in part from the National Science Foundation and GE Healthcare.
Given increasingly complex clinical demands and the traditional trade-off between CT image clarity and patient exposure to medical radiation, the efforts to develop and test MBiR were critical, said Jiang Hsieh, CT Chief Scientist for GE Healthcare. These efforts saw results the potential to lower noise, increase resolution, improve low contrast detectability and reduce artifacts while maintaining image clarity and today were able to offer Veo to physicians around the world, opening the door to high CT image performance at yet unseen low-dose levels.
Provided by University of Notre Dame
- Image filters improve image quality and lower patient radiation dose associated with CT scans May 03, 2010 | not rated yet | 0
- Men get ahead for being 'disagreeable' in the workplace; women don't Aug 04, 2011 | not rated yet | 0
- Simple reduction technique decreases radiation dose associated with CT scans of the head May 06, 2010 | not rated yet | 0
- Experts offer pointers for optimizing radiation dose in chest CT Sep 01, 2011 | not rated yet | 0
- Safer CT scanning for children developed Apr 04, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer 19 hours ago | not rated yet | 0
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer 20 hours ago | 5 / 5 (1) | 0
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer 23 hours ago | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer May 24, 2013 | 5 / 5 (2) | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer May 24, 2013 | 5 / 5 (4) | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
1 hour ago | not rated yet | 4
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
1 hour ago | not rated yet | 1
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
1 hour ago | not rated yet | 0
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
1 hour ago | not rated yet | 0
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
23 hours ago | 5 / 5 (3) | 0 |
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
20 hours ago | 3.7 / 5 (3) | 2 |